Varubi Prices, Coupons, Copay Cards & Patient Assistance
Varubi (rolapitant) is a member of the NK1 receptor antagonists drug class and is commonly used for Nausea/Vomiting - Chemotherapy Induced.
The cost for Varubi 90 mg oral tablet is around $718 for a supply of 2 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Varubi is available as a brand name drug only, a generic version is not yet available. View generic Varubi availability for more details.
Varubi prices
Oral Tablet
90 mg
Varubi oral tablet
from $717.54
for 2 tablets
Quantity | Per unit | Price |
---|---|---|
2 | $358.77 | $717.54 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Varubi Coupons, Copay Cards and Rebates
Varubi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Varubi Co-pay Assistance Program
Eligible commercially insured patients may pay $0 per prescription with savings of up to $200 per fill; maximum savings of $2000 per calendar year.
- Applies to:
- Varubi
- Number of uses:
- per prescription per calendar year
Form more information phone: 844-864-3014 or Visit website
Patient Assistance & Copay Programs for Varubi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Varubi (rolapitant) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: TerSera SupportSource: Varubi
Eligibility requirements:- Must have no prescription coverage for needed medication
- Based on FPL
- Not specified
- The patient must be a US citizen or possess a valid greencard to be eligible for this program
- Co-payment assistance, and patient assistance programs are available for eligible patients.
- Varubi (rolapitant) Tablet
More information please phone: 855-686-8725 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Varubi (rolapitant)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español
Patient resources
- Varubi drug information
- Varubi (Rolapitant Intravenous) (Advanced Reading)
- Varubi (Rolapitant Oral) (Advanced Reading)